<DOC>
	<DOCNO>NCT02210624</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy autologous bone marrow-derived stem cell therapy patient anaerobic ( hypoxic ) brain injury . Stem cell therapy emerge alternative treatment modality incurable intractable neurological disorder . This pilot study aim evaluate feasibility safety stem cell anaerobic brain injury .</brief_summary>
	<brief_title>Safety Efficacy Assessment Autologous Bone-marrow Derived Adult Mesenchymal Stem Cell Therapy Patients With Anoxic ( Hypoxic ) Brain Injury Pilot Trial</brief_title>
	<detailed_description>Various treatment modality minimize neurological deficit anoxic brain injury , include low consciousness , abnormal movement disorder , abnormal behavior , try , far effective proven method chronic patient . This study investigator initiate trial verify safety feasibility stem cell therapy patient anoxic brain injury .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Hypoxia , Brain</mesh_term>
	<criteria>Patients older 14 day index event occur oxygenfree brain injury patient Severe disability moderate due anoxic brain injury 18 year 75 year Patients 7 point less Glasgow coma scale ( GCS ) After resumption blood flow circulation . anaerobic unexpected ( hypoxic ) cerebral ischemia Encephalopathy ( It hypoxic brain ischemia induce due heart surgery , schedule ) Subjects agree write participate clinical research , view legal representative ( patient ) Patients require ventilator continue Patients extracorporeal membrane oxygenation ( ECMO ) index event occur time Patients history cardiac arrest prior occurrence Index event Endstage people less 12 month expect ( incurable ) disease patient Patients cardiac arrest occur due brain trauma severe Patients damage organ severe Patients bleed malignant current Pregnant patient Patients central nervous system tumor undergo radiation therapy chemotherapy If patient participate clinical trial , plan participate , patient three month end pass participate clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Anoxic Brain Injury</keyword>
	<keyword>Autologous bone marrow derive stem cell</keyword>
	<keyword>stoke</keyword>
</DOC>